Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia.

Literature DB >> 12377405

Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia.

Yen Kuang Yang¹, Leann Nelson, Lakshmi Kamaraju, William Wilson, Joseph P McEvoy.

Abstract

We applied nicotine 21 mg and matching placebo transdermal patches to thirty haloperidol-treated patients with schizophrenia who smoked. Clinical assessments of bradykinesia-rigidity were lower during nicotine patch administration than during placebo patch administration.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2002 PMID： 12377405 DOI： 10.1016/S0893-133X(02)00325-1

Source DB: PubMed Journal: Neuropsychopharmacology ISSN： 0893-133X Impact factor: 7.853

Keyword Cloud
Cited

12 in total

Review 1. Neurotensin agonists: potential in the treatment of schizophrenia.

Authors: Mona Boules; Amanda Shaw; Paul Fredrickson; Elliott Richelson
Journal: CNS Drugs Date: 2007 Impact factor: 5.749

Review 2. Co-morbidity of smoking in patients with psychiatric and substance use disorders.

Authors: David Kalman; Sandra Baker Morissette; Tony P George
Journal: Am J Addict Date: 2005 Mar-Apr

Review 3. Antipsychotic drug treatment for elderly people with late-onset schizophrenia.

Authors: Adib Essali; Ghassan Ali
Journal: Cochrane Database Syst Rev Date: 2012-02-15

Review 4. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.

Authors: Kristi A Sacco; Katie L Bannon; Tony P George
Journal: J Psychopharmacol Date: 2004-12 Impact factor: 4.153

5. A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia.

Authors: Mahtab Karkhane Yousefi; Timothy D Folsom; S Hossein Fatemi
Journal: J Addict Res Ther Date: 2011-12-20

6. Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.

Authors: Douglas L Boggs; Toral S Surti; Irina Esterlis; Brian Pittman; Kelly Cosgrove; R Andrew Sewell; Mohini Ranganathan; Deepak Cyril D'Souza
Journal: Schizophr Res Date: 2017-04-06 Impact factor: 4.939

Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia.

Review 1. Neurotensin agonists: potential in the treatment of schizophrenia.

Review 2. Co-morbidity of smoking in patients with psychiatric and substance use disorders.

Review 3. Antipsychotic drug treatment for elderly people with late-onset schizophrenia.

Review 4. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.

5. A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia.

6. Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.

7. Cigarette smoking and mental illness: a study of nicotine withdrawal.

Review 8. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

9. The effects of galantamine on psychopathology in chronic stable schizophrenia.

Review 10. Molecular targets for treating cognitive dysfunction in schizophrenia.